SCHEMBL2471103

SCHEMBL2471103

O=C(NCCCC1CC1)Oc1ccc(N2CCN(C(=O)c3ccc(F)cc3C(F)(F)F)CC2)nn1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SCD O00767 15/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2471365 0.95 SCD (0.75) SCD
SCHEMBL2463054 0.94 SCD (0.68) SCD
SCHEMBL2464906 0.89 SCD (0.74) SCD
SCHEMBL2470212 0.89 SCD (0.75) SCD
SCHEMBL2464781 0.87 SCD (0.62) SCD
SCHEMBL2464807 0.87 SCD (0.75) SCD
SCHEMBL2462958 0.86 SCD (0.68) SCD
SCHEMBL2464895 0.86 SCD (0.59) SCD
SCHEMBL2470099 0.86 SCD (0.70) SCD
SCHEMBL1380568 0.86 SCD (0.90) SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648874-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2011-10-05 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP claimed